TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients ...

India held an 8% share in global clinical trials - which evaluate the safety and effectiveness of new treatments - compared ...

India should take a page from the playbook of countries such as China and Australia if it wants a larger share of the global ...

Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET. Company Participants. Katie Hogan - Senior Director-Corporate Communications and Investo ...

The healthcare industry can be extremely stressful, and the added risk of assault can make that burden even heavier.

Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced that its President and CEO, Jayson Rieger, PhD, MBA, will ...

If Ford and the Progressive Conservatives win today’s provincial election, they will intensify healthcare privatization. The ...

Susan Doherty, the AHA’s vice president of field engagement, began the closing session of the 2025 Rural Health Care ...

If you thought Medicaid cuts wouldn’t affect you because you’re not on Medicaid, you couldn’t be more wrong. In Colorado, ...

The Carroll College Student Nurses Association and the Helena Health Science Advisory Board launched a free healthcare fusion event on Feb. 25.

Following the shooting at UPMC Memorial Hospital there have been renewed calls to increase security at health care facilities ...

About Septerna Septerna, Inc. is a biotechnology company pioneering a new era of GPCR drug discovery powered by its proprietary Native Complex Platform™. Its industrial-scale platform aims to unlock ...